PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, November 20, 2009: CNO, NRG, NOC, PFE, ANW and BSX

-- November 20, 2009 Conseco, Inc. (NYSE: CNO | Quote | Chart | News | PowerRating) at $5.08 on a volume of 912,406 shares

In a press release on November 20, Conseco Announces Reinsurance Transaction

CARMEL, Ind., Nov 20, 2009 Conseco, Inc. (NYSE: CNO | Quote | Chart | News | PowerRating) today announced a new agreement under which its Bankers Life and Casualty Company subsidiary ("Bankers Life") will coinsure, with an effective date of October 1, 2009, about 237,000 life insurance policies with Wilton Reassurance Company ("Wilton Re"). Wilton Re will pay a ceding commission of approximately $45 million and 50% coinsure these policies, which will continue to be administered by Bankers Life.

About Conseco

Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, critical illness and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's website at www.conseco.com.

-- November 20, 2009 NRG Energy (NYSE: NRG | Quote | Chart | News | PowerRating) trading at $23.55 on a volume of 791,637 shares

In a press release on November 20, NRG Energy, Inc. Announces Partial Redemption of 4.0% Convertible Preferred Stock

PRINCETON, N.J., Nov 20, 2009 NRG Energy (NYSE: NRG | Quote | Chart | News | PowerRating) announced today that it has called for redemption 210,000 of the 419,587 outstanding shares of its 4.0% Convertible Preferred Stock, representing approximately 50% of the total number of outstanding shares of preferred stock. The preferred stock redemption date will be December 21, 2009, and the redemption price will be $20.00 per share of preferred stock. The dividend payment due on December 15, 2009, on the preferred stock will be made in the usual manner.

About NRG Energy, Inc.

NRG Energy, Inc., a Fortune 500 company, owns and operates one of the country's largest and most diverse power generation portfolios. Headquartered in Princeton, NJ, the Company's power plants provide more than 24,000 megawatts of generation capacity--enough to supply more than 20 million homes. NRG's retail business, Reliant Energy, serves more than 1.6 million residential, business, commercial and industrial customers in Texas. A past recipient of the energy industry's highest honors--Platts Industry Leadership and Energy Company of the Year awards, NRG is a member of the U.S. Climate Action Partnership (USCAP), a group of business and environmental organizations calling for mandatory legislation to reduce greenhouse gas emissions. More information is available atwww.nrgenergy.com.

-- November 20, 2009 Northrop Grumman Corporation (NYSE:NOC) trading at $54.66 on a volume of 582,624 shares.

In a press release out on November 20, U.S. Air Force Awards $302.9 Million Production Contract to Northrop Grumman for Five Global Hawk High-Altitude, Long-Endurance Unmanned Aircraft Systems

SAN DIEGO, Nov 20, 2009 The U.S. Air Force has awarded Northrop Grumman Corporation (NYSE:NOC) a $302.9 million fixed price incentive fee contract for five RQ-4 Global Hawk high-altitude, long-endurance (HALE) unmanned aircraft systems (UAS). Under the Lot 7 production contract, the company will build two Block 30 systems and three Block 40 systems for the 303d Aeronautical Systems Group at Wright Patterson AFB in Dayton, Ohio.

The award also includes a ground station consisting of a launch and recovery element and a mission control element, plus two additional sensor suites that will be retrofitted into previous production aircraft. The contract runs through 2011.

About Northrop Grumman Corporation

Northrop Grumman Corporation is a leading global security company whose 120,000 employees provide innovative systems, products, and solutions in aerospace, electronics, information systems, shipbuilding and technical services to government and commercial customers worldwide.

-- November 20, 2009 Pfizer Inc. (NYSE: PFE | Quote | Chart | News | PowerRating) last at $18.42 a volume of 26.35M shares

In a press release out on November 20,FDA Approves Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations

NEW YORK, Nov 20, 2009 Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio(R) (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.

Revatio is indicated for the treatment of adult patients with pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening. The delay in clinical worsening was demonstrated when Revatio was added to background epoprostenol therapy. The efficacy of Revatio has not been adequately evaluated in patients taking bosentan concurrently. Revatio Injection is for the continued treatment of patients with pulmonary arterial hypertension who are currently prescribed Revatio Tablets but who are temporarily unable to take oral medication.

About Pfizer Inc.

Pfizer Inc. (NYSE: PFE | Quote | Chart | News | PowerRating) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals. It operates in two business segments: Pharmaceutical and Animal Health. Pfizer also operates several other businesses, including the manufacture of gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals. In June 2008, Pfizer completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals, Inc. through a merger of Pfizer's wholly owned subsidiary, Explorer Acquisition Corp., with and into Encysive. In June 2008, it also completed the acquisition of Serenex, Inc., a biotechnology company with a Heat Shock Protein 90 development portfolio. In July 2009, Pfizer bought back a 29.52% stake in its Indian arm, Pfizer Limited, increasing its stake to 70.75%.In October 2009, Pfizer Inc. acquired Wyeth.

-- November 20, 2009 Aegean Marine Petroleum Network Inc. (NYSE: ANW | Quote | Chart | News | PowerRating) last at $26.75 on a volume of 40,517 shares

In a press release out on November 20, Aegean Marine Petroleum Network Inc. Awarded Stand-By Oil Spill Recovery Services Contract by European Maritime Safety Agency

PIRAEUS, Greece, Nov 20, 2009 Aegean Marine Petroleum Network Inc. (NYSE: ANW | Quote | Chart | News | PowerRating) today announced its Belgian subsidiary, Aegean Bunkers at Sea N.V., has been awarded a contract by the European Maritime Safety Agency (EMSA) to increase the available oil pollution response capacity in the English Channel and its Atlantic approaches.

About Aegean Marine Petroleum Network Inc.

Aegean Marine Petroleum Network Inc. is an international marine fuel logistics company that markets and physically supplies refined marine fuel and lubricants to ships in port and at sea. The Company procures product from various sources (such as refineries, oil producers, and traders) and resells it to a diverse group of customers across all major commercial shipping sectors and leading cruise lines. Currently, Aegean has a global presence in 14 markets, including Vancouver, Montreal, Mexico, Jamaica, Trinidad and Tobago, West Africa, Gibraltar, U.K., Northern Europe, Piraeus, Patras, the United Arab Emirates, Singapore as well as Tangiers, Morocco.

-- November 20, 2009 Boston Scientific Corporation (NYSE: BSX | Quote | Chart | News | PowerRating) trading at $8.12 on a volume of 3.68M shares

In a press release out on November 20, Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets

NATICK, Mass. and LONDON, Nov 20, 2009 Boston Scientific Corporation (NYSE: BSX | Quote | Chart | News | PowerRating) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex(R) Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com

www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

CONTACT: PicksThatMove
e-mail: Info@picksthatmove.com
WWW: http://www.picksthatmove.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Northrop Grumman Corp (NOC) NOC. Northrop Grumman Corp (NOC) has Short Term PowerRatings at TradingMarkets. Details on Northrop Grumman Corp (NOC) Short Term PowerRatings is available at This Link.

For full details on Nrg Energy Inc (NRG) NRG. Nrg Energy Inc (NRG) has Short Term PowerRatings at TradingMarkets. Details on Nrg Energy Inc (NRG) Short Term PowerRatings is available at This Link.

For full details on Pfizer Inc (PFE) PFE. Pfizer Inc (PFE) has Short Term PowerRatings at TradingMarkets. Details on Pfizer Inc (PFE) Short Term PowerRatings is available at This Link.

For full details on Conseco Inc (CNO) CNO. Conseco Inc (CNO) has Short Term PowerRatings at TradingMarkets. Details on Conseco Inc (CNO) Short Term PowerRatings is available at This Link.

For full details on Boston Scientific Corp (BSX) BSX. Boston Scientific Corp (BSX) has Short Term PowerRatings at TradingMarkets. Details on Boston Scientific Corp (BSX) Short Term PowerRatings is available at This Link.

For full details on Aegean Marine Petroleum Network Inc (ANW) ANW. Aegean Marine Petroleum Network Inc (ANW) has Short Term PowerRatings at TradingMarkets. Details on Aegean Marine Petroleum Network Inc (ANW) Short Term PowerRatings is available at This Link.